title: [Study on anti-hyperlipidemia mechanism of high frequency herb pairs by molecular docking method].
abstract: Traditional Chinese medicine (TCM) has definitely clinical effect in treating hyperlipidemia, but the action mechanism still need to be explored. Based on consulting Chinese Pharmacopoeia (2010), all the lipid-lowering Chinese patent medicines were analyzed by associated rules data mining method to explore high frequency herb pairs. The top three couplet medicines with high support degree were Puerariae Lobatae Radix-Crataegi Fructus, Salviae Miltiorrhizae Radix et Rhizoma-Crataegi Fructus, and Polygoni Multiflori Radix-Crataegi Fructus. The 20 main ingredients were selected from the herb pairs and docked with 3 key hyperlipidemia targets, namely 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase), peroxisome proliferator activated receptor-α (PPAR-α ) and niemann-pick C1 like 1 (NPC1L1) to further discuss the molecular mechanism of the high frequency herb pairs, by using the docking program, LibDock. To construct evaluation rules for the ingredients of herb pairs, the root-mean-square deviation (RMSD) value between computed and initial complexes was first calculated to validate the fitness of LibDock models. Then, the key residues were also confirmed by analyzing the interactions of those 3 proteins and corresponding marketed drugs. The docking results showed that hyperin, puerarin, salvianolic acid A and polydatin can interact with two targets, and the other five compounds may be potent for at least one of the three targets. In this study, the multi-target effect of high frequency herb pairs for lipid-lowering was discussed on the molecular level, which can help further researching new multi-target anti-hyperlipidemia drug.
authors.forename: Lu-di
authors.initials: LD
authors.lastname: Jiang
authors.forename: Yu-su
authors.initials: YS
authors.lastname: He
authors.forename: Xi
authors.initials: X
authors.lastname: Chen
authors.forename: Ou
authors.initials: O
authors.lastname: Tao
authors.forename: Gong-Yu
authors.initials: GY
authors.lastname: Li
authors.forename: Yan-ling
authors.initials: YL
authors.lastname: Zhang
mesh_terms: D019659:Asteraceae / Q000737:chemistry*; D004365:Drugs, Chinese Herbal / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D006949:Hyperlipidemias / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*; D000960:Hypolipidemic Agents / Q000737:chemistry* / Q000378:metabolism; D008565:Membrane Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D026901:Membrane Transport Proteins; D062105:Molecular Docking Simulation; D047493:PPAR alpha / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D011485:Protein Binding; D029908:Pueraria / Q000737:chemistry*
chemical_list: D004365:Drugs, Chinese Herbal; D000960:Hypolipidemic Agents; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; C410800:NPC1L1 protein, human; D047493:PPAR alpha; D006903:Hydroxymethylglutaryl CoA Reductases